What is Winpro?
Established in 2016 and headquartered in Des Moines, Iowa, Winpro distinguishes itself by offering a unique line of blood protein supplements specifically formulated for canine health. The company operates within the rapidly expanding pet nutrition market, addressing a growing consumer demand for specialized dietary solutions for pets. Winpro's innovative approach to pet supplements positions it as a key player in enhancing animal well-being through targeted nutritional products.
How much funding has Winpro raised?
Winpro has raised a total of $3M across 1 funding round:
Series B
$3M
Series B (2021): $3M with participation from Next Level Ventures
Key Investors in Winpro
Next Level Ventures
Next Level Ventures is a prominent Iowa-based investment firm managing over $400 million, specializing in strategic investments from seed to growth stages, typically between $0.5 to $5.0 million. They focus on building partnerships, particularly in the fintech sector, and actively support portfolio companies with financial, operational, and networking assistance.
What's next for Winpro?
The substantial enterprise-level backing and recent strategic investment indicate Winpro is poised for significant scaling and market expansion. This capital infusion is likely to fuel further product development, enhance manufacturing capabilities, and broaden distribution channels. The company's focus on specialized pet nutrition, coupled with strategic financial backing, suggests a strong potential for continued innovation and market leadership in the competitive pet supplement industry. Future growth may involve exploring new product lines or expanding into international markets.
See full Winpro company page
